Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis

SnoringMouth BreathingTonsils
Written By Nicole Martinez

Increased nasal airflow resistance (NAR) may contribute to the pathophysiology of obstructive sleep apnoea syndrome (OSAS) but studies investigating the effects of relieving nasal obstruction in OSAS have produced differing results. There are no reports of intranasal corticosteroid therapy in adult OSAS patients with reversible nasal obstruction.

Nicole Martinez https://nvolvecollective.com
Previous

Association of Asthma and Allergic Rhinitis With Sleep-Disordered Breathing in Childhood
Next

Recognition of sleep-disordered breathing in children